tirzepatide cardiovascular outcomes trial with versus Dulaglutide in Type 2 Diabetes Abstract 4361308: Tirzepatide Reduces the

Plans may simplify approval requirements, helping patients avoid delays in starting therapy

Not all insurance covers the same diagnoses (such as obesity) or weight loss medications, including semaglutide

Off-label uses extend to alopecia areata, chemotherapy-induced hair loss, and telogen effluvium following hair transplant surgery

doi: 10.1038/s41398-018-0181-z 138 ChenCCHowieJEbrahimiMTeymouriKWooJJTiwariAKet al

Intern Info Lydia Hoffstaetter Lydia is currently a senior at Ithaca High School

This translates to potential variability in quality, consistency of dosage, and the presence of impurities, compared to brand-name counterparts